≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Brain, supratentorial

Endpoint Browser

CD2_BENIGN_BRAIN_SUPRATENT_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D33.0
  • Cause of death: ICD-10 — D33.0

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D33
Name in latin
Neoplasma benignum cerebri supratentoriale

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 587 339 248
Unadjusted period prevalence (%) 0.11 0.12 0.11
Median age at first event (years) 50.38 46.72 55.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
533
Matched controls
5328
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
271.5
221.2
213
13
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
202.3
181
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
33.3
197.4
271
160
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
135.3
124
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
1135.6
99.4
94
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
94.6
88
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
16.0
81.5
139
115
H02AB02
ATC
dexamethasone; systemic
51.6
78.6
94
22
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
73.7
69
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
60.3
70.6
82
16
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.8
69.0
152
208
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
20.8
62.7
95
55
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
60.6
57
*
N03AF02
ATC
oxcarbazepine; oral
17.6
57.9
93
63
AA1AD
NOMESCO Finland
CT of head and brain
4.9
53.0
220
673
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
195.6
51.9
53
*
D33.30
ICD-10 Finland
Acoustic neuroma
89.3
51.0
56
7
N03AX14
ATC
levetiracetam; systemic
18.1
46.8
74
47
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.8
46.7
69
36
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
23.3
45.7
66
32
130
Kela drug reimbursment
Malignant tumour
+∞
45.5
43
*
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
78.4
44.8
50
7
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
47.8
43.1
52
12
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
19.3
42.3
65
38
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
19.1
40.9
63
37
G91.1
ICD-10 Finland
Obstructive hydrocephalus
151.5
40.3
42
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
38.0
36
*
ZXC95
NOMESCO Finland
Use of surgical navigator
36.6
36.9
47
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.2
32.9
142
420
WF002
NOMESCO Finland
Radical radiotherapy
331.2
31.2
31
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.4
30.2
69
93
A04AA02
ATC
granisetron; systemic, transdermal
319.5
30.1
30
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
32.2
29.9
39
13
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.5
29.4
62
73
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
21.6
28.7
42
21
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.2
24
*
D33.04
ICD-10 Finland
Temporal lobe
+∞
25.2
24
*
R51.80
ICD-10 Finland
Headache
3.5
25.0
138
488
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
73.5
25.0
28
*
XCK00
NOMESCO Finland
Perimetry
5.6
24.9
77
157
C61
ICD-10 Finland
Malignant neoplasm of prostate
94.6
24.9
27
*
N03AB02
ATC
phenytoin; systemic
39.6
24.2
30
8
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
24.1
23
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.0
24.1
69
128
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
250.7
23.8
24
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
23.3
23.3
33
15
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
23.1
22
*
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
23.1
22
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
31.7
23.0
30
10
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
22.0
21
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
21.9
133
502
ZXE20
NOMESCO Finland
More than three and less than five hours
3.8
21.3
100
308
N03AF01
ATC
carbamazepine; oral, rectal
6.3
21.1
58
102
L01AX03
ATC
temozolomide; systemic
+∞
21.0
20
*
H53.4
ICD-10 Finland
Visual field defects
11.3
20.7
39
37
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
218.1
20.7
21
*
N03AG01
ATC
valproic acid; systemic, rectal
4.7
20.1
72
172
115
Kela drug reimbursment
Breast cancer
+∞
19.9
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
19.6
167
773
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
47.9
19.3
23
5
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
72.5
18.8
21
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
17.8
17
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
17.8
17
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
16.3
17.7
28
18
H02AB09
ATC
hydrocortisone; systemic
10.6
17.1
33
33
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
26.6
17.0
23
9
183
Kela drug reimbursment
Lamotrigin and topiramate
15.7
16.8
27
18
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
16.7
16
*
WX882
NOMESCO Finland
High dependency care
7.4
16.4
39
56
XX3DW
NOMESCO Finland
Time consuming IT work
5.5
16.4
49
96
G93.0
ICD-10 Finland
Cerebral cysts
34.5
15.8
20
6
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
34.5
15.8
20
6
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
15.7
15
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
15.7
15
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
164.5
15.6
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
164.5
15.6
16
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
15.5
96
360
2152
FHL
Extraction, big brain
+∞
14.6
14
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
14.6
14
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
82.4
14.6
16
*
E23.00
ICD-10 Finland
Panhypopituitarism
82.4
14.6
16
*
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
82.4
14.6
16
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
154.0
14.5
15
*
N03AX18
ATC
lacosamide; systemic
13.9
14.3
24
18
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.8
14.3
62
177
AA1BD
NOMESCO Finland
Extensive CT of head and brain
9.8
14.1
28
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
14.0
193
1105
D32.03
ICD-10 Finland
Benign meningioma in ventricles
+∞
13.6
13
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.6
13
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
+∞
13.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
143.4
13.5
14
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
143.4
13.5
14
*
R4110
NOMESCO Finland
Physiotherapy
2.3
13.3
146
752
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
12.6
13.2
23
19
N05BA09
ATC
clobazam; oral
19.6
13.0
19
10
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
12.9
207
1258
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
12.7
114
529
Z2445
NOMESCO Finland
Psychologist
4.4
12.6
46
112
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
71.6
12.6
14
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
71.6
12.6
14
*
N76
ICPC
Neoplasm nervous system unspecified
71.6
12.6
14
*
ZXC40
NOMESCO Finland
Use of ultrasound
32.9
12.6
16
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
32.9
12.6
16
5
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
12.5
12
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
12.5
12
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
12.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
132.9
12.5
13
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
10.9
12.4
23
22
Z3226
NOMESCO Finland
Physiotherapist
2.4
12.0
114
543
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
15.1
11.9
19
13
N88
ICPC
Epilepsy
16.9
11.7
18
11
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
11.5
11
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
122.5
11.5
12
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
11.5
35
71
G40.10
ICD-10 Finland
Simple partial seizures
15.5
11.4
18
12
AAF00
NOMESCO Finland
Ventriculostomy
20.6
11.2
16
8
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
11.1
65
234
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
14.3
11.0
18
13
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
61.2
10.7
12
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
112.1
10.5
11
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
112.1
10.5
11
*
N75
ICPC
Benign neoplasm nervous system
112.1
10.5
11
*
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
10.4
10
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
10.4
10
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
10.4
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
+∞
10.4
10
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
10.1
52
171
G40
ICD-10 Finland
Epilepsy
14.9
10.0
16
11
101
Kela drug reimbursment
Anterior pituitary hypofunction
14.9
10.0
16
11
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.9
123
660
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
26.6
9.8
13
5
L02AE02
ATC
leuprorelin; implant, parenteral
10.9
9.8
18
17
JN4AD
NOMESCO Finland
Body CT examination
5.7
9.8
27
49
WF099
NOMESCO Finland
Other radiotherapy
101.7
9.4
10
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
101.7
9.4
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
9.4
157
946
N03AX09
ATC
lamotrigine; oral
3.9
9.4
38
103
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
9.4
9
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
9.4
9
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
9.4
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
9.4
9
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
9.4
9
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
9.4
59
223
A04AA01
ATC
ondansetron; systemic, rectal
5.9
9.3
25
44
H53.2
ICD-10 Finland
Diplopia
5.0
9.3
29
61
TAB00
NOMESCO Finland
Lumbar puncture
3.7
9.3
40
115
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
9.3
71
301
Z3231
NOMESCO Finland
Registered nurse
1.9
9.2
147
871
ZXC86
NOMESCO Finland
Use of endoscopic device
19.0
9.0
13
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
9.0
80
368
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.5
8.9
12
5
R51
ICD-10 Finland
Headache
3.6
8.9
39
114
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
8.8
42
131
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.7
202
1356
JN4CD
NOMESCO Finland
Very extensive body CT
8.4
8.6
18
22
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
8.6
55
210
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
11.8
8.6
15
13
XKD00
NOMESCO Finland
Uroflowmetry
2.4
8.6
73
328
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
20.4
8.5
12
6
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
20.4
8.5
12
6
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
91.4
8.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
91.4
8.4
9
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
91.4
8.4
9
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
+∞
8.4
8
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
8.4
8
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.0
8.3
15
14
G91.0
ICD-10 Finland
Communicating hydrocephalus
14.8
8.2
13
9
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.6
8.1
61
255
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.6
8.1
58
236
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
22.4
8.0
11
5
N02BE01
ATC
paracetamol; systemic, rectal
1.9
8.0
428
3658
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
13.3
7.9
13
10
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.3
7.9
28
68
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.6
7.9
16
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
7.8
70
323
HAC20
NOMESCO Finland
Total mastectomy
45.6
7.7
9
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
45.6
7.7
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
7.6
100
546
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
25.4
7.6
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.6
114
655
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
81.1
7.4
8
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
+∞
7.3
7
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
7.3
7
*
ZZC00
NOMESCO Finland
Graft of fascia
+∞
7.3
7
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
D33.11
ICD-10 Finland
Brain stem
+∞
7.3
7
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
7.3
7
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
7.2
157
1023
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
30.4
7.2
9
*
L02BA01
ATC
tamoxifen; oral
20.3
7.2
10
5
D18.0
ICD-10 Finland
Haemangioma, any site
6.2
7.1
18
30
WX110
NOMESCO Finland
Local anesthesy
1.7
7.1
356
2914
WX402
NOMESCO Finland
General anaesthesia
2.2
7.1
75
375
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
6.9
117
700
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.8
6.9
16
24
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
6.8
29
84
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
16.9
6.8
10
6
G44.2
ICD-10 Finland
Tension-type headache
2.1
6.7
76
391
H47.2
ICD-10 Finland
Optic atrophy
10.2
6.6
12
12
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
70.6
6.4
7
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
70.6
6.4
7
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
6.4
53
233
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.3
6.4
13
16
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
+∞
6.3
6
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
+∞
6.3
6
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
+∞
6.3
6
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
6.3
6
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
6.3
6
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.3
6
*
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
6.3
71
364
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.0
6.2
8
*
A02BC02
ATC
pantoprazole; systemic
1.6
6.2
303
2423
Z2446
NOMESCO Finland
Social worker
2.6
6.2
43
172
N05AX08
ATC
risperidone; systemic
2.4
6.1
49
214
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.3
6.1
28
87

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
94
132
8.29
65.46
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
47
30
16.94
55.18
1.3
2.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
146
411
4.40
47.72
6.8
7.9
mmol/l
1.4
1.4
0.07
105
327
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
145
414
4.32
46.42
6.8
7.8
kpa
5.1
5.2
0.48
136
399
(3027801) Oxygen [Partial pressure] in Arterial blood
145
414
4.32
46.42
6.8
7.8
kpa
15.9
12.3
6.80
135
401
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
357
1977
3.06
37.93
7.5
5.5
mmol/l
1.2
1.2
1.81
335
1690
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
331
1782
2.97
36.62
7.0
5.0
mmol/l
1.2
1.2
3.81
313
1593
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
38
39
10.35
33.31
2.5
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
20
14.10
28.98
1.8
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
52
114
4.91
22.64
2.3
1.2
e6/l
2750.9
282.9
0.73
44
95
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
52
114
4.91
22.64
2.2
1.1
e6/l
16.2
3.4
0.89
44
92
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
51
112
4.89
22.15
2.0
1.2
mmol/l
3.5
3.8
0.69
46
104
(3044290) Cell count panel - Cerebral spinal fluid
48
101
5.09
21.90
2.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
376
2563
2.30
20.33
6.3
4.2
mmol/l
6.4
6.7
1.86
360
2348
(3016018) Differential panel - Cerebral spinal fluid
31
47
6.91
19.76
1.9
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
253
1485
2.24
19.54
2.4
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
106
425
2.82
18.72
3.4
1.8
nmol/l
302.6
365.9
2.63
97
385
(3033658) Prothrombin time (PT) actual/Normal
189
999
2.32
18.62
3.7
3.2
%
94.4
91.1
1.17
183
968
(3044640) Blood type and Crossmatch panel - Blood
216
1211
2.24
18.44
2.3
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
230
1326
2.21
18.30
2.6
2.1
u/l
273.7
276.6
0.01
222
1250
(3019060) Gas panel - Arterial blood
72
244
3.22
17.03
6.7
6.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
175
933
2.25
16.61
2.3
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
297
1953
2.05
16.18
3.7
3.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
130
619
2.41
15.99
2.3
1.8
s
28.1
29.7
3.72
130
600
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
114
549
2.34
13.50
7.0
6.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
296
2048
1.90
12.93
6.7
3.8
umol/l
9.6
12.0
5.40
279
1925
(3013650) Neutrophils [#/volume] in Blood by Automated count
342
2492
1.89
12.59
9.8
6.4
e9/l
4.3
4.1
0.36
296
2191
(3024561) Albumin [Mass/volume] in Serum or Plasma
251
1660
1.89
12.48
4.9
3.7
g/l
35.6
36.3
1.06
234
1544
(3020891) Body temperature
51
169
3.21
12.47
4.6
4.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
53
5.09
12.26
2.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
30
71
4.40
11.87
5.2
4.7
umol/l
373.7
386.1
0.16
25
61
(3018418) pH of Serum or Plasma
187
1144
1.93
11.62
4.4
2.9
ph
7.4
7.4
1.20
21
189
(3012095) Magnesium [Moles/volume] in Serum or Plasma
110
567
2.16
10.91
3.4
3.0
mmol/l
0.8
0.8
0.27
104
531
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
118
628
2.10
10.76
1.8
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
236
1594
1.80
10.51
6.2
8.5
inr
1.1
1.2
1.27
59
479
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
34
5.74
10.28
1.1
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
167
1022
1.89
10.16
6.4
4.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
413
3314
1.83
9.97
8.2
5.2
u/l
76.6
76.2
0.06
391
3066
(3001604) Monocytes [#/volume] in Blood
302
2245
1.71
9.24
6.7
5.4
e9/l
0.6
0.6
0.34
258
1964
(3019198) Lymphocytes [#/volume] in Blood
308
2319
1.69
8.85
6.7
5.4
e9/l
1.8
1.9
1.62
265
2064
(3013115) Eosinophils [#/volume] in Blood
309
2333
1.69
8.74
6.8
5.7
e9/l
0.2
0.2
1.27
270
2077
(3015377) Calcium [Moles/volume] in Serum or Plasma
195
1300
1.75
8.74
2.9
1.9
mmol/l
2.3
2.4
0.82
164
1108
(3006315) Basophils [#/volume] in Blood
301
2258
1.68
8.72
6.7
5.4
e9/l
0.0
0.0
0.73
257
1981
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
435
2.12
8.50
1.7
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
68
322
2.26
8.24
8.3
6.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
39
141
2.89
8.23
2.6
1.4
u/l
7.7
9.0
0.20
30
113
(3008295) Osmolality of Serum or Plasma
19
42
4.64
8.17
1.3
1.5
mosm/kgh2o
279.7
281.0
0.09
14
28
(3035637) Corticotropin [Mass/volume] in Plasma
19
42
4.64
8.17
1.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
84
435
2.09
8.13
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
159
1025
1.76
7.90
4.7
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
70
354
2.11
7.20
4.6
3.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
176
2.56
7.18
11.5
12.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
56
3.85
7.14
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
187
2.46
6.80
3.4
1.5
ug/l
4.6
4.2
0.07
35
140
(3026008) Bacteria identified in Urine by Culture
179
1236
1.64
6.74
3.6
2.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
21
59
3.65
6.65
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
71
372
2.03
6.65
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
222
1626
1.59
6.52
3.6
3.4
ng/l
49.1
58.3
0.13
152
1047
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
29
4.92
6.48
1.1
1.2
—
—
—
0
0
(4027681)
15
34
4.50
6.27
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
430
3685
1.62
6.22
4.9
3.9
pmol/l
14.5
14.6
0.24
404
3359
(42870588) Differential panel, method unspecified - Blood
199
1434
1.59
6.21
7.3
5.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
524
4750
1.96
6.08
17.7
10.7
mg/l
23.5
20.9
1.10
452
3575
(3023368) Bacteria identified in Blood by Culture
144
968
1.65
5.94
4.7
3.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
6
15.20
5.92
1.0
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
87
516
1.81
5.61
6.1
4.9
mmol/l
1.0
1.1
0.18
77
471
(3022096) Basophils/100 leukocytes in Blood
260
2023
1.51
5.59
6.7
5.6
%
0.7
0.7
0.04
243
1891
(3007853) Bacteria identified in Skin by Aerobe culture
80
467
1.83
5.43
1.7
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
90
546
1.77
5.38
1.6
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
60
323
1.96
5.22
2.4
2.5
g/l
10.4
10.7
0.20
55
299
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
49
3.54
5.21
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
37
166
2.31
5.12
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
153
1085
1.55
4.95
3.7
2.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
263
2095
1.46
4.82
6.7
5.5
%
2.7
3.0
1.12
247
1956
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
30
127
2.44
4.73
2.7
1.6
ug/l
1.7
1.7
0.00
23
113
(3013707) Erythrocyte sedimentation rate by Westergren method
398
3443
1.48
4.69
4.7
4.0
mm/h
10.9
10.2
0.39
372
3176
(3019069) Monocytes/100 leukocytes in Blood
263
2104
1.45
4.67
7.0
5.8
%
8.7
8.4
0.69
248
1976
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
235
2.04
4.64
1.7
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
116
783
1.60
4.62
3.0
2.5
mosm/kgh2o
559.8
556.1
0.06
100
647
(3018095) Leukocytes [#/volume] in Urine
197
1493
1.48
4.61
4.1
3.3
e6/l
41.9
96.2
1.24
146
1005
(3000850) Epithelial cells [#/volume] in Urine
123
845
1.58
4.54
2.7
2.3
e6/l
4.0
6.8
1.58
111
727
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
238
1877
1.45
4.52
2.3
2.3
nmol/l
73.1
75.3
0.78
215
1677
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
102
679
1.61
4.29
3.5
2.5
e6/l
1.5
1.0
0.71
66
381
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
221
2.02
4.28
2.4
1.3
iu/l
26.4
24.1
0.15
37
185
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
91
2.59
4.18
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
266
2167
1.42
4.12
6.8
5.5
%
27.6
29.2
1.49
251
2033
(3018010) Neutrophils/100 leukocytes in Blood
264
2150
1.41
4.09
6.4
5.3
%
57.5
56.4
0.79
249
2022
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
28
3.98
3.99
1.0
1.1
—
—
—
0
0
(4268621)
15
48
3.18
3.95
2.2
2.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
48
3.18
3.95
2.1
1.3
nmol/l
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
88
2.56
3.92
2.3
2.7
u/ml
0.4
0.4
—
9
46
(3019225) pH of Specimen
63
378
1.75
3.92
3.9
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
152
2.17
3.92
1.5
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
317
1.81
3.91
2.7
2.3
nmol/l
12.5
14.1
0.81
50
286
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
24
4.22
3.90
1.3
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
221
1757
1.41
3.88
2.1
1.9
pmol/l
93.7
96.2
0.34
108
911
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
103
704
1.56
3.86
2.9
1.9
mmol/l
2.4
2.4
0.43
89
605
(3044889) 12 lead EKG panel
365
3165
1.41
3.82
3.7
3.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
538
5045
1.80
3.82
16.4
10.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
149
1106
1.47
3.78
3.9
2.8
e6/l
0.3
0.4
0.67
122
806
(3022217) INR in Platelet poor plasma by Coagulation assay
80
518
1.63
3.76
17.5
20.7
inr
1.5
1.2
0.64
12
80
(3037467) Urinalysis macro (dipstick) panel - Urine
362
3144
1.39
3.70
4.9
3.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
174
1336
1.43
3.67
2.9
2.2
u/l
55.9
57.9
0.29
157
1237
(3002582) Erythrocytes [#/volume] in Urine
162
1228
1.44
3.67
3.7
2.8
e6/l
39.1
115.9
0.72
136
923
(3019150) Specific gravity of Urine by Refractometry
142
1052
1.46
3.62
5.1
3.4
kg/l
1.0
1.0
0.36
22
140
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
63
2.75
3.52
2.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
41
3.22
3.51
1.4
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
328
1.75
3.51
1.6
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
13
6.22
3.51
1.1
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
6
10.09
3.50
1.3
1.2
nmol/l
2.4
7.7
—
6
6
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
540
5089
1.76
3.49
12.2
8.2
u/l
27.4
26.3
0.57
527
4889
(1761868) Lipid panel - Serum or Plasma
139
1814
0.69
3.47
2.7
2.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
52
307
1.76
3.44
3.4
2.4
g/l
0.2
0.2
0.57
46
284
(3009261) Glucose [Presence] in Urine by Test strip
274
2295
1.36
3.39
4.6
3.3
estimate
0.0
0.0
0.50
39
380
(3029937) Albumin [Presence] in Urine by Test strip
156
1195
1.42
3.30
5.2
3.5
estimate
0.0
0.0
0.69
38
388
(3019309) Folate [Moles/volume] in Red Blood Cells
105
747
1.49
3.27
1.9
1.7
nmol/l
1101.4
1187.8
0.51
85
568
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
19
4.79
3.25
1.7
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
15
5.39
3.20
6.5
2.2
nmol/l
1.8
3.6
—
8
15
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
73
2.51
3.15
1.9
1.5
nmol/l
0.2
0.4
1.03
12
62
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
225
1.83
3.11
1.8
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
56
2.72
3.08
2.2
1.3
nmol/l
0.7
0.5
0.57
15
51
(3021589) Normoblasts [#/volume] in Blood
244
2030
1.35
3.07
9.4
7.6
e9/l
0.0
0.0
0.10
186
1670
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
68
2.54
3.06
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
29
3.49
3.06
3.8
2.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
280
1.74
3.03
2.9
3.8
kpa
5.0
5.1
0.36
41
266
(3021601) Nitrite [Presence] in Urine by Test strip
268
2266
1.34
3.00
6.0
4.5
estimate
0.0
0.0
0.00
39
395
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
5
10.07
2.98
1.6
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
33
177
1.92
2.97
1.8
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
266
2250
1.33
2.96
4.7
3.3
estimate
0.0
0.0
0.00
41
394
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
163
1.95
2.96
1.6
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
17
4.76
2.92
1.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
17
4.76
2.92
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
17
4.76
2.92
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
52
2.73
2.90
2.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
93
665
1.47
2.82
1.3
1.4
titre
378.2
541.9
0.98
22
146
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
18
4.49
2.80
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
18
4.49
2.80
1.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
183
1474
1.35
2.80
3.8
2.6
u/l
28.7
32.1
0.99
170
1411
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
89
633
1.48
2.77
3.6
2.6
e6/l
2.0
2.8
0.56
54
333
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
6
8.39
2.75
1.6
2.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
265
1.71
2.75
2.9
3.8
mmol/l
0.7
1.8
1.18
33
191
(3022313) Gas panel - Capillary blood
37
212
1.80
2.74
3.1
3.9
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
14
5.05
2.73
1.7
1.9
umol/l
26.5
16.2
—
7
14
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
140
1090
1.37
2.64
2.8
2.1
mg/l
2.8
2.9
0.28
117
927
(3022621) pH of Urine by Test strip
46
284
1.67
2.64
2.9
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
142
1.94
2.60
1.6
1.6
iu/ml
0.1
0.1
—
9
23
(3000494) Fungus identified in Specimen by Culture
72
497
1.51
2.60
1.4
1.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
8
20
4.04
2.57
1.3
1.1
mmol/l
33.1
27.6
—
8
20
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
20
4.04
2.57
1.1
1.1
umol/l
2.9
5.4
—
8
20
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
62
2.46
2.56
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
476
4434
1.39
2.50
5.5
4.5
mu/l
2.0
2.1
0.24
440
4076
(3002032) Base excess in Venous blood by calculation
58
386
1.56
2.47
4.6
3.3
mmol/l
2.1
1.9
0.16
50
307
(3014051) Protein [Presence] in Urine by Test strip
19
90
2.15
2.41
2.1
2.0
—
—
—
0
0
(4306422)
15
64
2.38
2.40
1.3
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
8
6.29
2.37
1.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
8
6.29
2.37
1.0
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
354
3175
1.29
2.35
4.2
2.9
u/l
51.6
41.8
1.56
337
2993
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
141
1121
1.34
2.31
2.9
2.9
ng/l
738.3
1113.3
1.61
120
943
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
85
2.15
2.31
1.5
1.6
—
—
—
0
0
(3015736) pH of Urine
212
1787
1.29
2.28
4.7
3.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
13
4.65
2.27
1.5
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
23
3.51
2.27
2.0
2.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
18
3.92
2.26
3.7
2.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
334
0.49
2.23
1.3
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
73
2.23
2.23
1.3
1.2
u/ml
4.6
7.3
—
10
35
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
9
5.59
2.21
1.2
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
36
2.81
2.21
2.6
4.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
80
2.16
2.20
1.5
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
156
1267
1.31
2.20
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
482
0.58
2.18
1.7
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
14
61
2.33
2.16
2.2
2.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
55
374
1.52
2.15
3.1
2.5
ug/l
7.0
7.0
0.01
49
329
(3001019) Free T4 and TSH panel - Serum or Plasma
14
290
0.47
2.14
1.4
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
468
4380
1.34
2.13
14.9
9.6
ml/min/173m2
86.5
84.5
1.04
402
3484
(3023520) Reticulocytes [#/volume] in Blood
47
310
1.56
2.11
2.8
2.4
e9/l
57.4
67.1
1.51
37
235
(3026361) Erythrocytes [#/volume] in Blood
560
5418
1.73
2.09
26.8
15.9
e12/l
4.5
4.6
2.48
555
5253
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
10
5.03
2.07
1.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
56
2.35
2.06
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
44
2.53
2.02
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
42
273
1.58
2.01
1.9
1.5
g/l
68.5
67.9
0.21
36
244
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
48
323
1.53
1.98
2.1
2.0
ml/min/173m2
70.9
71.0
0.01
14
131
(3021960) Folate [Moles/volume] in Serum or Plasma
125
998
1.32
1.98
1.6
1.5
nmol/l
20.2
21.0
0.17
107
857
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
18
91
2.01
1.97
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
45
2.47
1.94
1.2
1.7
u/ml
3.0
95.9
0.49
11
40
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
71
2.14
1.93
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
105
821
1.34
1.92
3.7
3.5
ng/l
80.2
372.9
2.73
73
590
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
245
1.59
1.89
1.5
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
22
3.21
1.88
1.0
1.0
miu/ml
1556.7
1740.5
—
7
22
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
797
1.34
1.87
1.6
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
28
2.88
1.86
1.6
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
59
422
1.44
1.83
2.7
2.2
%
1.6
1.7
0.23
50
382
(40768795) Lymph node Pathology biopsy report
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
322
1.50
1.80
1.5
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
146
1.74
1.80
1.8
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
23
3.07
1.80
1.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
47
2.37
1.78
2.3
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
550
0.65
1.77
1.4
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
18
3.36
1.75
1.2
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
18
3.36
1.75
1.2
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
54
2.25
1.75
1.0
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
13
3.87
1.72
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
72
541
1.38
1.70
4.4
4.4
%
31.4
32.0
0.21
54
351
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
62
2.12
1.66
1.3
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
62
2.12
1.66
1.5
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
240
2114
1.23
1.66
3.1
2.7
ug/l
106.0
99.6
0.26
217
1965
(3052851) Hemolysis interference index of Serum or Plasma
20
113
1.80
1.62
1.9
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
79
608
1.35
1.61
3.1
2.3
umol/l
13.3
13.9
0.30
70
561
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
84
1.93
1.61
1.1
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
44
2.29
1.54
1.2
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
235
1.52
1.50
2.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
116
1.75
1.50
4.5
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
65
2.02
1.49
1.3
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
294
1.46
1.48
4.9
3.8
ng/l
89.7
77.5
0.32
34
263
(3042936) Bacteria identified in Isolate by Culture
72
554
1.34
1.48
2.3
2.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
37
2.45
1.48
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
45
2.24
1.47
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
406
1.39
1.47
1.8
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
16
3.14
1.44
1.4
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
1.6
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
1.2
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
133
1117
1.25
1.41
2.4
2.3
umol/l
331.5
6339.3
3.97
117
984
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
40
2.27
1.40
1.4
1.8
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
29
2.43
1.39
1.3
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
29
2.43
1.39
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
53
2.10
1.39
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
89
1.82
1.38
1.6
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
207
1.53
1.38
4.4
3.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
65
500
1.34
1.35
3.5
2.4
%
20.8
24.2
1.38
54
437
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
128
1.66
1.35
1.3
1.4
g/l
7.4
7.6
0.36
14
99
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
128
1.66
1.35
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
128
1.66
1.35
1.3
1.4
g/l
3.7
4.0
0.50
13
95
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
54
2.06
1.33
1.6
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
118
985
1.25
1.32
2.0
1.7
mg/l
1.4
1.1
0.53
90
727
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
114
1.69
1.29
6.2
4.4
mg/l
1.2
1.4
1.04
19
104
(1001926) Buprenorphine [Presence] in Urine by Screen method
29
194
1.52
1.29
3.7
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
123
1.65
1.25
1.3
1.4
g/l
2.9
3.1
0.95
13
96
(40767503) Oxygen content in Capillary blood by calculation
13
70
1.88
1.24
2.3
2.5
%
18.2
16.3
—
7
35
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
201
1784
1.19
1.22
5.1
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
37
2.18
1.22
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
369
0.66
1.21
5.0
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
71
1.85
1.20
3.5
4.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
50
2.02
1.17
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
75
605
1.27
1.13
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
73
1.80
1.11
1.1
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
31
218
1.45
1.11
2.1
2.4
e6/l
0.2
0.2
0.34
31
208
(3025941) Bacteria identified in Stool by Culture
35
252
1.41
1.11
1.5
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
40
295
1.38
1.11
4.3
4.6
%
0.0
0.1
1.62
13
65
(46235355) HIV 1 and 2 tests - Meaningful Use set
119
1016
1.21
1.09
1.8
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
123
1054
1.21
1.09
5.0
4.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
39
288
1.38
1.08
3.7
4.6
%
0.6
0.4
—
10
56
(3037756) Immunofixation for Serum or Plasma
11
59
1.88
1.08
1.4
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
106
896
1.22
1.07
1.6
1.6
pmol/l
438.2
19522347.8
1.06
92
753
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
82
1.72
1.06
1.0
2.0
g/l
143.3
131.0
—
9
58
(3017181) Myelocytes/100 leukocytes in Blood
41
307
1.36
1.05
4.3
4.5
%
0.5
0.7
0.68
13
71
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
131
1.55
1.01
1.4
1.3
—
—
—
0
0
(4062490)
9
48
1.89
1.01
1.4
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
9
49
1.85
0.99
1.4
1.3
g/l
7.5
6.1
—
9
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
9
49
1.85
0.99
1.4
1.3
g/l
2.9
2.8
—
9
32
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
36
1.96
0.97
1.1
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
36
1.96
0.97
4.7
1.5
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
1.2
—
33.8
—
0
27
(40768443) Skin Pathology biopsy report
23
158
1.47
0.95
1.3
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
142
0.56
0.94
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
109
1.58
0.94
3.1
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
86
1.64
0.91
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
71
1.70
0.89
2.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
309
0.70
0.87
1.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
67
553
1.24
0.87
3.3
2.3
g/l
2.3
2.4
0.16
59
515
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
74
618
1.23
0.86
1.9
1.7
%
1.6
1.5
0.43
68
551
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
137
1.48
0.85
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
45
1.79
0.84
1.6
2.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
137
0.58
0.84
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
180
1.41
0.83
1.7
2.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
32
1.88
0.82
1.7
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
198
1.38
0.81
3.0
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
144
1286
1.16
0.80
4.9
3.7
ug/l
4.0
1.9
0.90
128
1154
(3020961) Endomysium IgA Ab [Titer] in Serum
31
234
1.34
0.79
1.2
1.2
—
167.3
—
0
7
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.6
—
1.1
—
0
17
(3041806) Other cells [#/volume] in Blood by Manual count
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
33
1.83
0.79
2.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
46
368
1.27
0.78
1.1
1.2
iu/ml
174.8
145.0
0.16
18
163
(3041096) Erythrocytes [Presence] in Urine by Automated
114
1291
0.85
0.78
4.0
2.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
281
1.30
0.74
4.6
4.8
%
0.0
0.1
0.60
11
56
(3005033) Fetal Nuchal fold Thickness US
8
136
0.58
0.73
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
874
1.17
0.73
1.3
1.3
iu/ml
37.4
31.2
0.11
27
266
(3036603) Volume of Urine
5
25
2.01
0.73
1.2
1.6
—
2310.6
—
0
5
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
25
2.01
0.73
1.2
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(44790047)
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(44790048)
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
(44806118)
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
(44790049)
7
40
1.76
0.71
1.6
1.6
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(3013512) EKG study
134
1201
1.15
0.71
3.8
3.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
101
1.50
0.70
1.5
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
178
1.36
0.70
1.4
1.3
miu/ml
179.0
263.0
—
10
88
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
180
0.66
0.68
1.3
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
42
1.67
0.68
1.4
1.1
—
94.4
—
0
5
(3016879) Cocaine [Presence] in Urine
30
232
1.31
0.67
3.6
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
1.2
1.4
ug/l
3.9
6.1
—
5
23
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
70
1.58
0.65
2.5
3.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
13
87
1.51
0.63
3.8
2.1
u/ml
109.2
148.2
0.12
13
69
(4010399)
40
326
1.24
0.61
1.5
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.1
—
3233.0
—
0
11
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
115
1033
1.14
0.60
4.6
3.6
%
22.6
24.1
0.56
65
448
(3023199) Leukocytes [#/volume] in Pleural fluid
0
21
0.00
0.60
0.0
1.1
—
3225.4
—
0
12
(3012441) Differential panel - Pleural fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
53
1.52
0.58
1.9
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
52
439
1.20
0.58
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
36
1.67
0.57
2.0
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
160
0.68
0.56
2.3
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
350
3359
1.10
0.55
3.1
3.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
60
1.51
0.54
1.9
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
169
1.31
0.54
6.8
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
82
727
1.15
0.53
2.7
2.6
ug/l
0.8
0.7
0.36
53
449
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
117
1.38
0.52
1.5
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
100
1.41
0.52
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
252
1.24
0.50
3.5
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
67
1.50
0.50
1.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
67
1.50
0.50
2.3
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
167
0.71
0.50
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
167
0.71
0.50
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
167
0.71
0.50
1.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
212
0.75
0.49
1.3
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
253
1.24
0.49
3.5
1.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
52
448
1.18
0.48
3.2
2.4
umol/l
8.6
7.3
0.18
40
390
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
166
0.72
0.48
1.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
48
1.46
0.47
2.7
1.8
%
91.2
90.4
—
7
48
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
416
4044
1.10
0.46
20.7
12.9
%
13.6
13.5
0.82
416
3949
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
112
1.35
0.45
2.6
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
37
312
1.20
0.44
6.2
2.6
e9/l
3.6
4.0
0.43
27
245
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
130
0.69
0.43
1.1
1.7
—
—
—
0
0
(4024509)
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
32
1.57
0.42
1.6
2.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(4133840)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
114
1.32
0.41
1.2
1.2
—
11.9
—
0
7
(21494434) Karyotype in Bone marrow
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
18
0.00
0.40
0.0
5.1
—
29.5
—
0
5
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
251
1.21
0.40
3.6
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
61
1.32
0.39
1.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
187
1.24
0.39
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
142
1.28
0.39
2.1
1.9
nmol/l
36.3
38.2
0.15
18
136
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
213
0.79
0.37
1.4
1.8
mg/l
2.7
3.3
—
9
155
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
115
0.69
0.37
1.5
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
143
1.27
0.37
1.2
1.2
—
2.9
—
0
16
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
81
738
1.11
0.36
1.9
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
52
585
0.88
0.36
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
41
469
0.86
0.36
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
81
1.36
0.36
3.7
3.1
e9/l
4.2
4.1
0.07
11
81
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
135
1.27
0.35
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
80
0.62
0.35
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
82
1.35
0.34
4.1
3.4
%
60.6
56.3
0.56
11
82
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
136
1.26
0.34
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
464
4712
0.93
0.29
4.5
4.2
mmol/l
4.7
4.7
0.41
439
4394
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
76
1.32
0.28
1.4
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
44
394
1.13
0.28
4.2
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
140
1.22
0.27
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
77
1.30
0.26
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
44
398
1.11
0.24
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
76
1.19
0.24
1.1
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
76
1.19
0.24
1.3
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
318
0.87
0.24
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
73
679
1.09
0.24
1.8
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
39
1.28
0.23
1.2
1.3
e6/l
2387.2
172000.0
—
5
27
(3009508) Creatinine [Moles/volume] in Urine
152
1456
1.06
0.23
4.4
3.2
mmol/l
8.1
7.8
0.25
132
1238
(3008898) HLA-B27 [Presence]
25
219
1.15
0.22
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
79
1.27
0.22
1.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
146
0.82
0.22
1.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
42
1.19
0.21
1.0
1.4
—
—
—
0
0
(4146454)
5
42
1.19
0.21
3.6
2.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
25.7
—
0
11
(3003129) Base excess in Capillary blood by calculation
0
10
0.00
0.21
0.0
1.1
—
1.4
—
0
10
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
426
4322
0.95
0.21
5.9
5.5
mmol/mol
38.3
39.6
2.64
395
4034
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
98
1.23
0.21
2.1
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
126
1.20
0.21
2.0
1.9
iu/l
2.0
6.4
—
6
44
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
13
0.00
0.21
0.0
1.4
—
8.6
—
0
8
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
98.8
—
0
13
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
259
1.13
0.20
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
13
108
1.21
0.20
2.2
1.9
pmol/l
177.4
234.8
0.88
13
100
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
155
1.17
0.20
1.6
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
463
4684
0.95
0.20
4.5
4.2
mmol/l
1.5
1.5
0.55
433
4346
(3023419) Bacteria identified in Sputum by Culture
6
51
1.18
0.19
6.2
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
454
4485
1.05
0.19
19.9
11.7
%
39.4
40.5
2.01
320
3370
(3027944) Amphetamines [Presence] in Urine
28
251
1.12
0.19
3.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
106
1012
1.06
0.18
1.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
147
1.16
0.18
2.3
3.0
g/l
0.3
0.3
—
8
55
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
465
4600
1.05
0.17
4.8
4.2
mmol/l
5.7
5.9
2.86
424
4197
(3012516) Albumin [Mass/volume] in Urine
134
1290
1.05
0.17
3.4
3.3
mg/l
38.1
213.5
1.27
95
811
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
474
4787
0.95
0.17
5.0
4.7
mmol/l
2.8
2.8
0.03
442
4442
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
321
1.10
0.16
2.9
3.1
ng/l
173.5
184.8
0.05
30
295
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
120
1.17
0.16
1.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
1164
1.05
0.16
1.5
1.3
u/ml
1.0
2.3
1.11
28
312
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
130
0.84
0.16
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
447
4517
0.96
0.16
4.0
3.8
mmol/l
1.2
1.3
0.41
417
4173
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.2
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
104
1000
1.05
0.14
1.6
1.3
g/l
2.4
2.4
0.01
60
611
(3002523) Influenza virus A Ag [Presence] in Specimen
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
860
1.04
0.10
1.3
1.3
u/ml
4.3
10.4
1.00
35
333
(3005570) Glucose [Moles/volume] in Urine
5
44
1.14
0.10
1.2
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
48
1.04
0.09
1.0
3.4
mmol/l
6.0
6.6
—
5
35
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
60
578
1.04
0.08
1.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
59
611
0.96
0.07
1.4
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
72
0.83
0.07
1.3
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.2
—
75.1
—
0
5
(3021788) Differential panel - Synovial fluid
7
83
0.84
0.07
1.4
1.6
—
—
—
0
0
(4034850)
17
157
1.09
0.07
8.5
9.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
118
1.10
0.07
1.2
1.2
u/ml
0.1
3.0
—
5
54
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
162
0.92
0.06
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
62
604
1.03
0.05
2.8
2.4
ug/g
104.0
105.1
0.01
46
470
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
110
1.09
0.05
1.6
1.4
ug/g
300.3
319.1
—
7
62
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
129
0.93
0.03
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
102
1.08
0.03
1.0
1.1
u/ml
0.1
0.8
—
5
54
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
278
0.97
0.02
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
79
798
0.99
0.01
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
123
1238
0.99
0.01
1.7
1.6
mmol/l
1.5
1.4
0.50
109
1052
(3020682) Albumin/Creatinine [Ratio] in Urine
137
1362
1.01
0.01
4.1
4.1
mg/mmol
6.5
9.3
0.43
93
860
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
105
1.05
0.00
1.0
1.1
u/ml
1.1
5.3
—
6
64
(1002224) Polysomnography panel
23
235
0.98
0.00
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
127
1.02
0.00
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
173
0.98
0.00
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
21
207
1.02
0.00
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
109
1.01
0.00
7.8
3.7
—
—
—
0
0
(4094501)
12
119
1.01
0.00
1.5
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
14
139
1.01
0.00
1.2
1.1
—
13.2
—
0
15
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
379
1.00
0.00
4.0
2.1
u/l
33.7
45.2
0.39
31
316
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
90
1.00
0.00
9.4
2.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.0
—
0.6
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
57
0.88
0.00
3.6
2.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
61
0.98
0.00
1.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.8
—
1.2
—
0
8
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
3.0
—
19.8
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.7
—
0
7
(3044941) Cell count panel - Synovial fluid
7
69
1.01
0.00
1.9
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
70
1.00
0.00
1.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
58
0.86
0.00
3.6
2.3
mmol/l
105.6
105.7
—
5
58
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
170.7
—
0
9
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
58
0.86
0.00
3.6
2.3
mmol/l
3.7
4.1
—
5
58
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.8
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.0
—
0
6
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
16.4
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT_EXALLC – Benign neoplasm: Brain, supratentorial

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).